| 標題 |
內容 |
來源 |
更新時間 |
| MedSci Healthcare |
MedSci Health is the leading integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Medical Affair Service Organization, is purpose-built to accelerate customer performance to address modern market realities. |
前往 |
2024-11-13 16:45 |
| 首席招聘官_中國企業首席招聘官專屬讀本_一覽英才網 |
首席招聘官雜志，中國企業首席招聘官專屬讀本，引領人才招聘創新思維，提供人才招聘與人才管理的深刻見解，搭建中國企業人力資源管理者（CEO/CHO/CHD/CHM)參與、交流、分享的平臺，打造新時代中國企業的首席招聘官！ |
前往 |
2024-12-08 06:01 |
| SYNthesis Med Chem |
|
前往 |
2024-12-12 07:35 |
|
Contract Research Organization | R&D Services | Pharmaron
|
A premier R&D service provider for the life sciences industry, Pharmaron offers diverse R&D service capabilities ranging from medicinal and analytical chemistry, pharmacology, drug safety assessment and radiochemistry, chemical & pharmaceutical development to clinical development. |
前往 |
2024-12-12 07:53 |
| 凱銳斯 |
上海凱銳斯生物科技有限公司 |
前往 |
2024-12-12 08:01 |
| 《2021大健康產業高質量發展大會》_聚智創新，融合發展_與智博會同行_藥智網 |
聚智創新，融合發展，與智博會同行！《2021大健康產業高質量發展大會暨第六屆中國醫藥研發·創新峰會》將于2021年9月18-19日在重慶舉行，本次會議邀請醫藥監管領域領導、醫藥行業頂尖專家、領軍人物、企業高管、研發精英等，圍繞國家政策及行業趨勢，創新藥物發展戰略與研發策略，醫藥大數據與人工智能等前沿熱門話題進行廣泛而深入的探討。 |
前往 |
2024-12-18 11:47 |
| A Custom Synthesis Company - Capot Chemical |
Capot Chemical is a Custom Synthesis Company. At Capot,We can synthesize and manufacture your complex molecules from 1 gram to 10+tons.CMO,CDMO,CRO,FTE,R&D Company. |
前往 |
2025-01-07 00:10 |
| 小分子CRO_CDMO_CMO_化學原料藥_生物制劑_重慶博騰制藥科技股份有限公司 |
博騰制藥，博騰股份，CRO，CDMO，CMO，原料藥，晶型研究，小分子CRO_CDMO_CMO_化學原料藥_生物制劑" name="keywords" />
|
前往 |
2024-11-11 10:43 |
|
Contract Research Organization(CRO) | Preclinical CRO | Medicilon Inc |
Medicilon,a contract research organization(CRO), can provide one-stop integrated services including Biology, Chemistry and Preclinical services. Medicilon has been recognized as one of the professional drug discovery preclinical CRO in China. |
前往 |
2024-12-12 07:54 |
| 銀星集團 |
銀星集團是一家以實業投資、產業地產開發與運營為主營業務的跨行業綜合性高科技企業集團。以深圳為總部，業務輻射北京、上海、武漢、惠州、貴州等地，行業涉及人工智能、信息技術、生物制藥、產業地產等領域。 |
前往 |
2024-11-13 04:10 |
